drugset / Trial / NCT02953379

Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis

NCT02953379

Phase 3 Withdrawn EMS
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate the non-inferiority of the clinical efficacy of the mometasone nasal gel in the treatment of allergic rhinitis.

Timeline

Start
2019-05
Primary completion
2019-12
Completion
2020-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Mometasone Other / unclassified Intranasal

Indications